receptor tyrosine kinase - Globe Thesis

Keyword [receptor tyrosine kinase] Result: 141 - 160 \| Page: 8 of 10
141.	Correlation Between PD-L1 Expression And EGFR Mutation In Lung Adenocarcinoma
142.	Modulation Of ALDHA1 Activity Reverses Stem-like Cell-mediated EGFR-TKI Resistance In NSCLC
143.	MiR-625-3p Modulates Gefitinib Resistance Through AXL In Non-small Cell Lung Cancer
144.	Clinical Characteristics And Molecular Mechanism Of Transformation From Adenocarcinoma To Small-cell Lung Cancer In EGFR Mutant Patients After EGFR-TKI
145.	Efficacy Of Chemotherapy And Oral Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor In Lung Adenocarcinoma
146.	The Prognosis Of Transmembrane Receptor Tyrosine Kinase AXL And C-MET In Gastrointestinal Tumors
147.	Clinical Study Of "Qing Xuan Fei Re Fa" On The Efficacy Of Skin Rash After Applying EGFR-TKI In Patients With Lung Cancer
148.	Analysis Of Clinical Effect And Gene Monitoring Of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor In The Treatment Of Advanced Non-small Cell Lung Cancer
149.	The Latest Progress Of Targeted Therapy Non-samll Cell Lung Cancer With Brain Metastases
150.	Study Of Isolation And Identification Of Tumorstem-like Cell From ID8 Cell Line And Its Vaccine Effects
151.	Docetaxel Plus Platinum Versus Pemetrexed Plus Platinum As Subsequent Treatment Of Advanced Lung Adenocarcinoma With Acquired Resistance To EGFR-TKI,Gefitinib
152.	Clinical Observation Of EGFR-TKIs Combined With WBRT Versus EGFR-TKIs Alone In The Treatment Of Patients With EGFR-sensitive Mutant Lung Adenocarcinoma With Inital Brain Metastases
153.	The Analysis Of Treatment Effect By Different Strategies For Advanced Lung Adenocarcinoma Patients With EGFR Sensitive Mutation Positive
154.	The Study On The Mechanism Of CXCR4 In T Cell Acute Lymphoblastic Leukemia Cell Migration
155.	Clinical Study On The Influential Factors Of Aquired Resistance To EGFR-TKI And The Treatment Strategy After Drug Resistance In Non-small Cell Lung Cancer
156.	Study On EGFR-TKIs Resistance And BIN1 Expression In Lung Adenocarcinoma
157.	The Case Analysis Of Epidermal Growth Factor Receptor-targeted Therapies Combined With Chemoradiotherapy In Esophageal Squamous Cell Carcinoma And Literature Review
158.	Clinical Outcomes Of Surgery Combined With Targeted Therapy In Non-Small Cell Lung Cancer
159.	Dynamic Monitoring Of Lymphocyte Subpopulation During The EGFR-TKI Therapy For Predicting The Efficacy And Resistance Of EGFR-TKI In EGFR Mutated Lung Cancer Patients
160.	The Role Of Receptor Tyrosine Kinase Axl In The Pathogenesis Of Intracranial Aneurysms
<<First <Prev Next> Last>> Jump to